281 related articles for article (PubMed ID: 12891212)
1. Pioglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with type 2 diabetes mellitus: an intravascular ultrasound scanning study.
Takagi T; Yamamuro A; Tamita K; Yamabe K; Katayama M; Mizoguchi S; Ibuki M; Tani T; Tanabe K; Nagai K; Shiratori K; Morioka S; Yoshikawa J
Am Heart J; 2003 Aug; 146(2):E5. PubMed ID: 12891212
[TBL] [Abstract][Full Text] [Related]
2. Troglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with non-insulin dependent diabetes mellitus: a serial intravascular ultrasound study.
Takagi T; Akasaka T; Yamamuro A; Honda Y; Hozumi T; Morioka S; Yoshida K
J Am Coll Cardiol; 2000 Nov; 36(5):1529-35. PubMed ID: 11079654
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone reduces neointima volume after coronary stent implantation: a randomized, placebo-controlled, double-blind trial in nondiabetic patients.
Marx N; Wöhrle J; Nusser T; Walcher D; Rinker A; Hombach V; Koenig W; Höher M
Circulation; 2005 Nov; 112(18):2792-8. PubMed ID: 16246947
[TBL] [Abstract][Full Text] [Related]
4. A prospective, multicenter, randomized trial to assess efficacy of pioglitazone on in-stent neointimal suppression in type 2 diabetes: POPPS (Prevention of In-Stent Neointimal Proliferation by Pioglitazone Study).
Takagi T; Okura H; Kobayashi Y; Kataoka T; Taguchi H; Toda I; Tamita K; Yamamuro A; Sakanoue Y; Ito A; Yanagi S; Shimeno K; Waseda K; Yamasaki M; Fitzgerald PJ; Ikeno F; Honda Y; Yoshiyama M; Yoshikawa J;
JACC Cardiovasc Interv; 2009 Jun; 2(6):524-31. PubMed ID: 19539256
[TBL] [Abstract][Full Text] [Related]
5. Thiazolidinedione treatment attenuates diffuse neointimal hyperplasia in restenotic lesions after coronary stent implantation in type 2 diabetic patients: an intravascular ultrasound study.
Takagi T; Yamamuro A; Tamita K; Katayama M; Morioka S
J Cardiol; 2005 Apr; 45(4):139-47. PubMed ID: 15875535
[TBL] [Abstract][Full Text] [Related]
6. Angiographic and three-dimensional intravascular ultrasound analysis of combined intracoronary beta radiation and self-expanding stent implantation in human coronary arteries.
Ferrero V; Ribichini F; Heyndrickx GR; De Bruyne B; Piessens M; Carlier S; Büchi M; Matullo G; Vassanelli C; Wijns W
Am J Cardiol; 2004 Nov; 94(10):1237-42. PubMed ID: 15541237
[TBL] [Abstract][Full Text] [Related]
7. Effect of plaque debulking before stent implantation on in-stent neointimal proliferation: a serial 3-dimensional intravascular ultrasound study.
Takeda Y; Tsuchikane E; Kobayashi T; Terai K; Kobayashi Y; Nakagawa T; Sakurai M; Awata N; Kobayashi T
Am Heart J; 2003 Jul; 146(1):175-82. PubMed ID: 12851628
[TBL] [Abstract][Full Text] [Related]
8. Pioglitazone inhibits in-stent restenosis in atherosclerotic rabbits by targeting transforming growth factor-beta and MCP-1.
Joner M; Farb A; Cheng Q; Finn AV; Acampado E; Burke AP; Skorija K; Creighton W; Kolodgie FD; Gold HK; Virmani R
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):182-9. PubMed ID: 17068283
[TBL] [Abstract][Full Text] [Related]
9. Oral rapamycin to prevent human coronary stent restenosis: a pilot study.
Guarda E; Marchant E; Fajuri A; Martínez A; Morán S; Mendez M; Uriarte P; Valenzuela E; Lazen R
Am Heart J; 2004 Aug; 148(2):e9. PubMed ID: 15309012
[TBL] [Abstract][Full Text] [Related]
10. Cellular and molecular changes associated with inhibitory effect of pioglitazone on neointimal growth in patients with type 2 diabetes after zotarolimus-eluting stent implantation.
Hong SJ; Kim ST; Kim TJ; Kim EO; Ahn CM; Park JH; Kim JS; Lee KM; Lim DS
Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2655-65. PubMed ID: 21030718
[TBL] [Abstract][Full Text] [Related]
11. Reduction of neointimal hyperplasia after coronary stenting by pioglitazone in nondiabetic patients with metabolic syndrome.
Katayama T; Ueba H; Tsuboi K; Kubo N; Yasu T; Kuroki M; Saito M; Momomura S; Kawakami M
Am Heart J; 2007 May; 153(5):762.e1-7. PubMed ID: 17452150
[TBL] [Abstract][Full Text] [Related]
12. Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation.
Takano M; Inami S; Jang IK; Yamamoto M; Murakami D; Seimiya K; Ohba T; Mizuno K
Am J Cardiol; 2007 Apr; 99(8):1033-8. PubMed ID: 17437723
[TBL] [Abstract][Full Text] [Related]
13. High-dose intracoronary irradiation after de novo stent implantation results of the EVEREST (Evaluation of Endoluminal Radiation in Elective Stenting) trial.
Geiger MH; Ludwig J; Burckhard R; Scheinert D; Müller RG; Daniel WG; Sauer R; Strnad V
Strahlenther Onkol; 2006 Jan; 182(1):9-15. PubMed ID: 16404515
[TBL] [Abstract][Full Text] [Related]
14. Randomized blinded clinical trial of intracoronary brachytherapy with 90Sr/Y beta-radiation for the prevention of restenosis after stent implantation in native coronary arteries in diabetic patients.
Syeda B; Schukro C; Kirisits C; Lang I; Siostrzonek P; Gottsauner-Wolf M; Pokrajac B; Schmid R; Yahya N; Pötter R; Glogar D
Radiother Oncol; 2006 Jan; 78(1):60-6. PubMed ID: 16309769
[TBL] [Abstract][Full Text] [Related]
15. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial.
Sabaté M; Jiménez-Quevedo P; Angiolillo DJ; Gómez-Hospital JA; Alfonso F; Hernández-Antolín R; Goicolea J; Bañuelos C; Escaned J; Moreno R; Fernández C; Fernández-Avilés F; Macaya C;
Circulation; 2005 Oct; 112(14):2175-83. PubMed ID: 16203930
[TBL] [Abstract][Full Text] [Related]
16. Effects of stem cell therapy with G-CSF on coronary artery after drug-eluting stent implantation in patients with acute myocardial infarction.
Kang HJ; Kim YS; Koo BK; Park KW; Lee HY; Sohn DW; Oh BH; Park YB; Kim HS
Heart; 2008 May; 94(5):604-9. PubMed ID: 18070947
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, randomized, placebo-controlled multicenter clinical trial to evaluate the effects of the angiotensin II receptor blocker candesartan cilexetil on intimal hyperplasia after coronary stent implantation.
Radke PW; Figulla HR; Drexler H; Klues HG; Mügge A; Silber S; Daniel W; Schmeisser A; Reifart N; Motz W; Büttner HJ; Fischer D; Ortlepp JR; Schaefers K; Hoffmann R; Hanrath P;
Am Heart J; 2006 Oct; 152(4):761.e1-6. PubMed ID: 16996855
[TBL] [Abstract][Full Text] [Related]
18. Restenosis is not associated with stent length in a pig model of coronary stent implantation.
Koutouzis M; Papalois A; Kyrzopoulos S; Dafnomili P; Kyriakides ZS
Cardiol J; 2008; 15(5):458-62. PubMed ID: 18810722
[TBL] [Abstract][Full Text] [Related]
19. Role of pioglitazone in the prevention of restenosis and need for revascularization after bare-metal stent implantation: a meta-analysis.
Patel D; Walitt B; Lindsay J; Wilensky RL
JACC Cardiovasc Interv; 2011 Mar; 4(3):353-60. PubMed ID: 21435616
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of pioglitazone in patients with ST elevation myocardial infarction treated with primary stent implantation.
Kaneda H; Shiono T; Miyashita Y; Takahashi S; Taketani Y; Domae H; Matsumi J; Mizuno S; Minami Y; Sugitatsu K; Saito S
Heart; 2009 Jul; 95(13):1079-84. PubMed ID: 19321493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
